Clinical Sensitivity of SARS-CoV-2 Nucleic Acid Amplification Tests for Diagnosing COVID-19
Jessica P. Ridgway, Jennifer Pisano, Emily Landon, Kathleen G. Beavis, Ari Robicsek
Abstract
Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplification test (NAAT) results from 2 health systems, we estimated the clinical sensitivity of a single SARS-CoV-2 NAAT. We found that SARS-CoV-2 NAAT has 82%-97% sensitivity for diagnosing coronavirus disease 2019 among symptomatic patients.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Nucleic Acid Amplification TestsVirology2019-20 coronavirus outbreakSars virusSensitivity (control systems)Internal medicineOutbreakInfectious disease (medical specialty)DiseaseChlamydia trachomatisElectronic engineeringEngineeringSARS-CoV-2 detection and testingCOVID-19 diagnosis using AISARS-CoV-2 and COVID-19 Research